{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:13:02Z","timestamp":1773702782162,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS058046"],"award-info":[{"award-number":["U01NS058046"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","award":["U01NS058046"],"award-info":[{"award-number":["U01NS058046"]}],"id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS058046"],"award-info":[{"award-number":["U01NS058046"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cbi.2019.05.015","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:04:50Z","timestamp":1557831890000},"page":"194-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure"],"prefix":"10.1016","volume":"308","author":[{"given":"Palmer","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyong","family":"Yan-Jye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah","family":"Momper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela Andrea","family":"Camacho-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Radic'","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zrinka","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Sit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Barry","family":"Sharpless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.05.015_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0006-3002(55)90040-8","article-title":"A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase","volume":"18","author":"Wilson","year":"1955","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2019.05.015_bib2","first-page":"87","volume":"vol. 5","author":"Froede","year":"1971"},{"key":"10.1016\/j.cbi.2019.05.015_bib3","series-title":"Anticholinesterase Agents in Goodman & Gilman's Pharmacological Basis of Therapeutics","first-page":"161","author":"Taylor","year":"2018"},{"key":"10.1016\/j.cbi.2019.05.015_bib4","first-page":"451","article-title":"In search of an effective in vivo reactivator for organophosphorus nerve agent-inhibited acetylcholinesterase in the central nervous system","volume":"4","author":"Shih","year":"2012","journal-title":"Adv. Studies in Biology"},{"key":"10.1016\/j.cbi.2019.05.015_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1126\/science.1166305","article-title":"Delivery of a quaternary pyridine salt across the blood-brain barrier by its dihydropyridine derivative","volume":"190","author":"Bodor","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.cbi.2019.05.015_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2012.09.012","article-title":"Evaluation and computational characterization of facilitated transport of Glu carbon C-1 oxime reactivators across a blood-brain barrier model","volume":"203","author":"Bhonsle","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.05.015_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tox.2015.12.001","article-title":"Novel substituted phenoxyalkyl pyridinium oxime enhance survival and attenuate seizure like behavior of rat receiving lethal levels of nerve agent surrogates","volume":"339","author":"Chambers","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2019.05.015_bib8","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1002\/chem.201801394","article-title":"Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration","volume":"24","author":"Zorbaz","year":"2018","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.cbi.2019.05.015_bib9","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00204-016-1772-1","article-title":"Toxicology of organophosphorus compounds in view of an increasing terrorist threat","volume":"90","author":"Worek","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2019.05.015_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.118.249383","article-title":"Pharmacology, pharmacokinetics and tissue disposition of zwitterionic hyroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure","volume":"367","author":"Sit","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"532\u2013538","key":"10.1016\/j.cbi.2019.05.015_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0041-008X(66)90065-2","article-title":"Reversal of a soman-induced effect on neuromuscular function without a reactivation of cholinesterase","volume":"8","author":"Loomis","year":"1966","journal-title":"Toxicol. App.Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.015_bib12","first-page":"414","article-title":"Successful oxime therapy one hour after soman intoxication in the rat","volume":"49","author":"Wolthus","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.015_bib13","series-title":"Principles of Drug Action","first-page":"1","article-title":"Molecular basis of pharmacologic selectivity; chapter 1","author":"Taylor","year":"1990"},{"key":"10.1016\/j.cbi.2019.05.015_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/10408444.2016.1220916","article-title":"Sarin (GB, O-isopropyl methyl phosphonofluoridate neurotoxicity: a critical review","volume":"46","author":"Abou-Donia","year":"2016","journal-title":"Critcal Reviews in Toxicology"},{"key":"10.1016\/j.cbi.2019.05.015_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces the need for better anticholinesterase drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2019.05.015_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin exposure in Japan. Acute toxicity and long terms effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2019.05.015_bib17","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1073\/pnas.90.11.5128","article-title":"An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase","volume":"90","author":"Ripoll","year":"1993","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.cbi.2019.05.015_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/0006-2952(65)90120-6","article-title":"Action of fluoride on cholinesterase II. In vitro reactivation of cholinesterases inhibited by organophosphorus compounds","volume":"14","author":"Heilbronn","year":"1965","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.015_bib19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1096\/fasebj.30.1_supplement.1191.4","article-title":"Abs. Oxime reactivation mechanisms for organophosphate conjugated human acetylcholinesterase","volume":"30","author":"Hou","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2019.05.015_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cbi.2005.10.026","article-title":"The role of AChE active site gorge in determining stereo-selectivity of charged and uncharged VX enantiomers","volume":"157","author":"Ordentlich","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.05.015_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bj20021862","article-title":"Acetylcholinesterase active center and gorge combinatorial mutations and enantiomeric phosphonates","volume":"373","author":"Kovarik","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.05.015_bib22","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1021\/bi036191a","article-title":"Mutant cholinesterases possessing enhanced capacity for reaction of their phosphonylated conjugates","volume":"43","author":"Kovarik","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2019.05.015_bib23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/jacs.5b11384","article-title":"Steric and dynamic parameters influencing in situ cycloadditions to form triazole inhibitors with crystalline acetylcholinesterase","volume":"138","author":"Bourne","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2019.05.015_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0031-6997(25)06940-6","article-title":"The role of central cholinergic neurons in the regulation of blood pressure in experimental hypertension","volume":"48","author":"Buccafusco","year":"1996","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2019.05.015_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1474-8673.1986.tb00645.x","article-title":"Target sites for acetylcholinesterases on the ventral surface of the medulla oblongata: hypotension elicited by organophosphate agents","volume":"6","author":"Edery","year":"1986","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.015_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2017.07.003","article-title":"Post-exposure treatment with oxime RS 194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor","volume":"274","author":"Rosenberg","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.05.015_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2017.10.025","article-title":"Post-exposure treatment with the oxime RS 194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques","volume":"293","author":"Rosenberg","year":"2018","journal-title":"Tox. Letters"},{"key":"10.1016\/j.cbi.2019.05.015_bib28","series-title":"Goodman and Gilman's Pharmacological Basis of Therapeutics","first-page":"65","article-title":"Membrane transporters and drug response","author":"Giacomini","year":"2018"},{"issue":"7688","key":"10.1016\/j.cbi.2019.05.015_bib29","article-title":"Blood-brain barrier penetrant and orally bioavailable antidotes to organophosphate poisoning","volume":"32","author":"Shyong","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2019.05.015_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbi.2018.09.004","article-title":"Efficacy of atropine sulfate\/obidoxime co-formulation against sarin exposure in Guinea pigs","volume":"296","author":"Joosen","year":"2018","journal-title":"Chem. Biol. Interact."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719306623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719306623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:57:27Z","timestamp":1757858247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719306623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"alternative-id":["S0009279719306623"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.05.015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}